Whipple's disease unmasked by TNF inhibitor therapy for treatment of seronegative rheumatoid arthritis.
Hepatitis and other GI infections
Infection (gastroenterology)
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
21 Jul 2022
21 Jul 2022
Historique:
pmc-release:
21
07
2024
entrez:
21
7
2022
pubmed:
22
7
2022
medline:
26
7
2022
Statut:
epublish
Résumé
We report a patient with seronegative rheumatoid arthritis diagnosed with Whipple's disease following treatment of tumour necrosis factor inhibitor (TNFI) therapy. Whipple's disease should be considered in patients with seronegative rheumatoid arthritis and other unexplained multisystem illness. The TNFI therapy and immunosuppressive therapies can unmask latent Whipple's disease.
Identifiants
pubmed: 35863856
pii: 15/7/e250693
doi: 10.1136/bcr-2022-250693
pmc: PMC9310182
pii:
doi:
Substances chimiques
Tumor Necrosis Factor Inhibitors
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.